ADAPTIMMUNE THERAPEUTICS PLC

09338148
Active Abingdon

Research and experimental development on biotechnology

0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

ADAPTIMMUNE THERAPEUTICS PLC

09338148

Research and experimental development on biotechnology

Founded 3 Dec 2014 Active Abingdon, England 0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

ADAPTIMMUNE THERAPEUTICS LIMITED 3 Dec 2014 — 1 Apr 2015
Accounts Submitted 31 May 2026 Next due 30 Jun 2026 13 days remaining
Confirmation
Net assets £9M £22M 2024 year on year
Total assets £196M £26M 2024 year on year
Total Liabilities £187M £4M 2024 year on year
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

60 Jubilee Avenue Milton Park Abingdon Oxfordshire OX14 4RX England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ADAPTIMMUNE THERAPEUTICS PLC (09338148), an active life sciences and medical technology company based in Abingdon, England. Incorporated 3 Dec 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type group
Next accounts 31 Dec 2025
Due by 30 Jun 2026 13 days remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

£120.84M

Increased by £5.47M (+5%)

Net Assets

£9.44M

Decreased by £21.58M (-70%)

Total Liabilities

£186.61M

Decreased by £4.27M (-2%)

Turnover

£141.91M

Increased by £61.67M (+77%)

Employees

N/A

Decreased by 449 (-100%)

Debt Ratio

95%

Increased by 9 (+10%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 1Sept 2014Series A
Investor 2Sept 2014Series A
Investor 3Sept 2014Series A

Share Capital

Share Capital

Share allotments and capital structure

764 Allotments 1,522,796,123 Shares £539.23m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
12 May 2025162,600£6k£0.038
9 May 2025150,000£6k£0.038
7 May 20251,800,000£68k£0.038
6 May 20252,006,370£75k£0.038
30 Apr 2025240,372£8k£0.034

Officers

Officers

1 active 2 resigned
Status
Adrian George RawcliffeDirectorBritishUnited States541 Sept 2019Active

Shareholders

Shareholders (1)

National City Nominees Limited Citigroup Centre Canada Square Canary Wharf London Middlesex England E14 5lb
100.0%
1,528,649,624

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

ADAPTIMMUNE THERAPEUTICS PLC Current Company
ADAPTIMMUNE LIMITED united kingdom

Charges

Charges

2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
31 May 2026AccountsAnnual accounts made up to 31 Dec 2025
25 Mar 2026AddressChange Registered Office Address Company With Date Old Address New Address
25 Mar 2026AddressChange Registered Office Address Company With Date Old Address New Address
17 Nov 2025OfficersTermination of David Morrell Mott as director on 14 Nov 2025
17 Nov 2025OfficersTermination of Priti Hegde as director on 14 Nov 2025
31 May 2026 Accounts

Annual accounts made up to 31 Dec 2025

25 Mar 2026 Address

Change Registered Office Address Company With Date Old Address New Address

25 Mar 2026 Address

Change Registered Office Address Company With Date Old Address New Address

17 Nov 2025 Officers

Termination of David Morrell Mott as director on 14 Nov 2025

17 Nov 2025 Officers

Termination of Priti Hegde as director on 14 Nov 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

2 weeks ago on 31 May 2026

Change Registered Office Address Company With Date Old Address New Address

2 months ago on 25 Mar 2026

Change Registered Office Address Company With Date Old Address New Address

2 months ago on 25 Mar 2026

Termination of David Morrell Mott as director on 14 Nov 2025

7 months ago on 17 Nov 2025

Termination of Priti Hegde as director on 14 Nov 2025

7 months ago on 17 Nov 2025